• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

揭示祖先线索:探索哥伦比亚人群中CCR5 ∆32突变频率以用于艾滋病毒/艾滋病治疗。

Unveiling ancestral threads: Exploring CCR5 ∆32 mutation frequencies in Colombian populations for HIV/AIDS therapeutics.

作者信息

Barrios-Navas Alejandro, Nguyen Thanh Long, Gallo Juan Esteban, Mariño-Ramírez Leonardo, Soto José María Satizabal, Sánchez Adalberto, Jordan I King, Valderrama-Aguirre Augusto

机构信息

Grupo Instituto de Investigaciones Biomédicas, Departamento de Ciencias Biológicas, Facultad de Ciencias, Universidad de Los Andes, Bogotá, DC, Colombia.

School of Biological Sciences, Georgia Institute of Technology, Atlanta, GA, USA.

出版信息

Infect Genet Evol. 2024 Nov;125:105680. doi: 10.1016/j.meegid.2024.105680. Epub 2024 Oct 5.

DOI:10.1016/j.meegid.2024.105680
PMID:39374819
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11563905/
Abstract

AIDS remains a significant global health challenge since its emergence in 1981, with millions of deaths and new cases every year. The CCR5 ∆32 genetic deletion confers immunity to HIV infection by altering a cell membrane protein crucial for viral entry. Stem cell transplants from homozygous carriers of this mutation to HIV-infected individuals have resulted in viral load reduction and disease remission, suggesting a potential therapeutic avenue. This study aims to investigate the relationship between genetic ancestry and the frequency of the CCR5 ∆32 mutation in Colombian populations, exploring the feasibility of targeted donor searches based on ancestry composition. Utilizing genomic data from the CÓDIGO-Colombia consortium, comprising 532 individuals, the study assessed the presence of the CCR5 ∆32 mutation and examined if the population was on Hardy-Weinberg equilibrium. Individuals were stratified into clusters based on African, American, and European ancestry percentages, with logistic regression analysis performed to evaluate the association between ancestry and mutation frequency. Additionally, global genomic databases were utilized to visualize the worldwide distribution of the mutation. The findings revealed a significant positive association between European ancestry and the CCR5 ∆32 mutation frequency, underscoring its relevance in donor selection. African and American ancestry showed negative but non-significant associations with CCR5 ∆32 frequency, which may be attributed to the study's limitations. These results emphasize the potential importance of considering ancestry in donor selection strategies, reveal the scarcity of potential donors in Colombia, and underscore the need to consider donors from other populations with mainly European ancestry if the CCR5 ∆32 stem cell transplant becomes a routine treatment for HIV/AIDS in Colombia.

摘要

自1981年出现以来,艾滋病仍然是一项重大的全球卫生挑战,每年有数百万例死亡和新发病例。CCR5 ∆32基因缺失通过改变一种对病毒进入至关重要的细胞膜蛋白,赋予对HIV感染的免疫力。将这种突变的纯合携带者的干细胞移植到HIV感染个体中,已导致病毒载量降低和疾病缓解,这表明了一种潜在的治疗途径。本研究旨在调查哥伦比亚人群中遗传血统与CCR5 ∆32突变频率之间的关系,探索基于血统构成进行靶向供体搜索的可行性。利用来自CÓDIGO - 哥伦比亚联盟的532名个体的基因组数据,该研究评估了CCR5 ∆32突变的存在情况,并检查该人群是否处于哈迪 - 温伯格平衡。个体根据非洲、美洲和欧洲血统百分比分层,进行逻辑回归分析以评估血统与突变频率之间的关联。此外,利用全球基因组数据库来可视化该突变在全球的分布。研究结果显示欧洲血统与CCR5 ∆32突变频率之间存在显著正相关,突出了其在供体选择中的相关性。非洲和美洲血统与CCR5 ∆32频率呈负相关但不显著,这可能归因于该研究的局限性。这些结果强调了在供体选择策略中考虑血统的潜在重要性,揭示了哥伦比亚潜在供体的稀缺性,并强调如果CCR5 ∆32干细胞移植成为哥伦比亚HIV/AIDS的常规治疗方法,需要考虑来自其他主要为欧洲血统人群的供体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a251/11563905/67371a3d58fb/nihms-2027897-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a251/11563905/f25b8dca2818/nihms-2027897-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a251/11563905/791565f3a5fa/nihms-2027897-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a251/11563905/de778587c583/nihms-2027897-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a251/11563905/67371a3d58fb/nihms-2027897-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a251/11563905/f25b8dca2818/nihms-2027897-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a251/11563905/791565f3a5fa/nihms-2027897-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a251/11563905/de778587c583/nihms-2027897-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a251/11563905/67371a3d58fb/nihms-2027897-f0004.jpg

相似文献

1
Unveiling ancestral threads: Exploring CCR5 ∆32 mutation frequencies in Colombian populations for HIV/AIDS therapeutics.揭示祖先线索:探索哥伦比亚人群中CCR5 ∆32突变频率以用于艾滋病毒/艾滋病治疗。
Infect Genet Evol. 2024 Nov;125:105680. doi: 10.1016/j.meegid.2024.105680. Epub 2024 Oct 5.
2
Frequency of the CCR5 delta 32 mutant allele in HIV-1-positive patients, female sex workers, and a normal population in Taiwan.台湾地区HIV-1阳性患者、女性性工作者及正常人群中CCR5 Δ32突变等位基因的频率。
J Formos Med Assoc. 1997 Dec;96(12):979-84.
3
[Single nucleotide polymorphisms of HIV coreceptor CCR5 gene in Chinese Yi ethnic group and its association with HIV infection].[中国彝族人群HIV辅助受体CCR5基因单核苷酸多态性及其与HIV感染的相关性]
Zhonghua Yi Xue Za Zhi. 2005 Nov 30;85(45):3181-5.
4
Mutational analysis of the CCR5 and CXCR4 genes (HIV-1 co-receptors) in resistance to HIV-1 infection and AIDS development among intravenous drug users.静脉吸毒者中CCR5和CXCR4基因(HIV-1共受体)对HIV-1感染和艾滋病发展的抗性的突变分析。
Hum Genet. 1998 Apr;102(4):483-6. doi: 10.1007/s004390050726.
5
Genotype and allele frequency of a 32-base pair deletion mutation in the CCR5 gene in various ethnic groups: absence of mutation among Asians and Pacific Islanders.不同种族人群CCR5基因32碱基对缺失突变的基因型和等位基因频率:亚洲人和太平洋岛民中无此突变。
Int J Infect Dis. 1999 Summer;3(4):186-91. doi: 10.1016/s1201-9712(99)90022-x.
6
Legacy of a magic gene-: From discovery to clinical benefit in a generation.一代传奇的魔基因——从发现到临床获益仅用了一代人的时间。
Proc Natl Acad Sci U S A. 2024 Mar 19;121(12):e2321907121. doi: 10.1073/pnas.2321907121. Epub 2024 Mar 8.
7
Frequency of CCR5 delta-32 mutation in human immunodeficiency virus (HIV)-seropositive and HIV-exposed seronegative individuals and in general population of Medellin, Colombia.哥伦比亚麦德林市人类免疫缺陷病毒(HIV)血清阳性及HIV暴露后血清阴性个体和普通人群中CCR5 Δ32突变的频率。
Mem Inst Oswaldo Cruz. 2000 Mar-Apr;95(2):237-42. doi: 10.1590/s0074-02762000000200018.
8
Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study.CCR2和CCR5变体对HIV-1感染及疾病进展的遗传影响对比。血友病生长与发育研究(HGDS)、多中心艾滋病队列研究(MACS)、多中心血友病队列研究(MHCS)、旧金山城市队列(SFCC)、ALIVE研究。
Science. 1997 Aug 15;277(5328):959-65. doi: 10.1126/science.277.5328.959.
9
Distribution of HIV/AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population.HIV/AIDS保护性基因SDF1、CCR5和CCR2变体在克里特岛人群中的分布情况。
J Clin Virol. 2005 Dec;34(4):310-4. doi: 10.1016/j.jcv.2005.01.010.
10
Frequency of CCR5-Delta32 deletion in human immunodeficiency virus type 1 (HIV-1) in healthy blood donors, HIV-1-exposed seronegative and HIV-1-seropositive individuals of southern Brazilian population.巴西南部人群中健康献血者、HIV-1暴露血清阴性者及HIV-1血清阳性者体内1型人类免疫缺陷病毒(HIV-1)中CCR5-Δ32缺失的频率
Int J Mol Med. 2008 Nov;22(5):669-75.

引用本文的文献

1
The Consortium for Genomic Diversity, Ancestry, and Health in Colombia (CÓDIGO): building local capacity in genomics and bioinformatics.哥伦比亚基因组多样性、血统与健康联盟(CÓDIGO):建设基因组学和生物信息学方面的本地能力。
Commun Biol. 2025 Jul 17;8(1):1062. doi: 10.1038/s42003-025-08496-9.
2
Targeting Latent HIV Reservoirs: Effectiveness of Combination Therapy with HDAC and PARP Inhibitors.靶向潜伏性HIV储存库:HDAC与PARP抑制剂联合治疗的有效性
Viruses. 2025 Mar 12;17(3):400. doi: 10.3390/v17030400.

本文引用的文献

1
HIV cure: Are we going to make history?HIV 治愈:我们是否将要创造历史?
HIV Med. 2024 Mar;25(3):322-331. doi: 10.1111/hiv.13557. Epub 2023 Oct 11.
2
Prevalence of R5 and X4-Tropic strains in HIV-1 Infected bangladeshi population.R5和X4嗜性毒株在孟加拉国HIV-1感染人群中的流行率。
Indian J Med Microbiol. 2023 Sep-Oct;45:100377. doi: 10.1016/j.ijmmb.2023.100377. Epub 2023 May 24.
3
Multitargeted drug design strategy for discovery of short-peptide-based HIV-1 entry inhibitors with high potency.用于发现高效能短肽基HIV-1进入抑制剂的多靶点药物设计策略。
Eur J Med Chem. 2023 Apr 5;252:115294. doi: 10.1016/j.ejmech.2023.115294. Epub 2023 Mar 16.
4
Genome-wide data from medieval German Jews show that the Ashkenazi founder event pre-dated the 14 century.从中世纪德国犹太人的全基因组数据来看,阿什肯纳兹人的祖先事件发生在 14 世纪之前。
Cell. 2022 Dec 8;185(25):4703-4716.e16. doi: 10.1016/j.cell.2022.11.002. Epub 2022 Nov 30.
5
The Impact of Ethnicity and Genetic Ancestry on Disease Prevalence and Risk in Colombia.种族和遗传血统对哥伦比亚疾病患病率及风险的影响。
Front Genet. 2021 Sep 17;12:690366. doi: 10.3389/fgene.2021.690366. eCollection 2021.
6
Continental-scale genomic analysis suggests shared post-admixture adaptation in the Americas.大陆范围的基因组分析表明,美洲存在混合后的适应性共享。
Hum Mol Genet. 2021 Nov 1;30(22):2123-2134. doi: 10.1093/hmg/ddab177.
7
The Phenotypic Consequences of Genetic Divergence between Admixed Latin American Populations: Antioquia and Chocó, Colombia.遗传分化的表型后果:哥伦比亚的安蒂奥基亚和乔科。
Genome Biol Evol. 2020 Sep 1;12(9):1516-1527. doi: 10.1093/gbe/evaa154.
8
International meta-analysis of PTSD genome-wide association studies identifies sex- and ancestry-specific genetic risk loci.国际 PTSD 全基因组关联研究的荟萃分析确定了性别和祖先特异性的遗传风险位点。
Nat Commun. 2019 Oct 8;10(1):4558. doi: 10.1038/s41467-019-12576-w.
9
Genetic analyses of diverse populations improves discovery for complex traits.对不同人群的遗传分析可提高复杂性状的发现能力。
Nature. 2019 Jun;570(7762):514-518. doi: 10.1038/s41586-019-1310-4. Epub 2019 Jun 19.
10
Population Pharmacogenomics for Precision Public Health in Colombia.哥伦比亚精准公共卫生的群体药物基因组学
Front Genet. 2019 Mar 22;10:241. doi: 10.3389/fgene.2019.00241. eCollection 2019.